Kevin Rakin - 31 Aug 2021 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
Director
Signature
/s/ Kevin Rakin
Issuer symbol
ORMP
Transactions as of
31 Aug 2021
Net transactions value
$0
Form type
4
Filing time
02 Sep 2021, 16:44:59 UTC
Previous filing
11 Aug 2021
Next filing
20 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Award +10,000 +15% 78,104 31 Aug 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Units ("RSUs") granted in February 2021 and vested upon achievement of certain vesting conditions. The RSUs convert into Issuer's common stock on a one-for-one basis.